Cargando…

Multi-omics characterization and therapeutic liability of ferroptosis in melanoma

Detalles Bibliográficos
Autores principales:	He, Yi, Dong, Yu, Chen, Yong, Zhang, Guanxiong, Zhang, Hailun, Lei, Guang, Du, Yanhua, Chen, Xiang, Ye, Youqiong, Liu, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363465/ https://www.ncbi.nlm.nih.gov/pubmed/35945204 http://dx.doi.org/10.1038/s41392-022-01067-y

Ejemplares similares

Multi-omics characterization of autophagy-related molecular features for therapeutic targeting of autophagy
por: Luo, Mei, et al.
Publicado: (2022)

Tumor-associated macrophages, dendritic cells, and neutrophils: biological roles, crosstalk, and therapeutic relevance
por: Shen, Mingyi, et al.
Publicado: (2022)

Ferroptosis as a promising therapeutic strategy for melanoma
por: Ta, Na, et al.
Publicado: (2023)

Multi-omics Analysis of Ferroptosis Regulation Patterns and Characterization of Tumor Microenvironment in Patients with Oral Squamous Cell Carcinoma
por: Gu, Wenchao, et al.
Publicado: (2021)

Targeting ferroptosis in melanoma: cancer therapeutics
por: Khorsandi, Khatereh, et al.
Publicado: (2023)

Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2023)

Multi-Platform Omics Analysis for Identification of Molecular Characteristics and Therapeutic Targets of Uveal Melanoma
por: Kim, Yong Joon, et al.
Publicado: (2019)

Therapeutic Implications of Ferroptosis in Renal Fibrosis
por: Zhang, Yao, et al.
Publicado: (2022)

Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy
por: Jing, Ying, et al.
Publicado: (2020)

Ferroptosis Mediation Patterns Reveal Novel Tool to Implicate Immunotherapy and Multi-Omics Characteristics in Bladder Cancer
por: Liu, Jingchao, et al.
Publicado: (2022)

Multi-omics for COVID-19: driving development of therapeutics and vaccines
por: Guo, Mengyu, et al.
Publicado: (2023)

Identification of CircRNA signature associated with tumor immune infiltration to predict therapeutic efficacy of immunotherapy
por: Dong, Yu, et al.
Publicado: (2023)

Multi-Omics Analysis of Cancer Cell Lines with High/Low Ferroptosis Scores and Development of a Ferroptosis-Related Model for Multiple Cancer Types
por: Shan, Guangyao, et al.
Publicado: (2021)

Ferroptosis, radiotherapy, and combination therapeutic strategies
por: Lei, Guang, et al.
Publicado: (2021)

Integrative Analysis Identifies Multi-Omics Signatures That Drive Molecular Classification of Uveal Melanoma
por: Mo, Qianxing, et al.
Publicado: (2021)

Identification of immune-related ferroptosis prognostic marker and in-depth bioinformatics exploration of multi-omics mechanisms in thyroid cancer
por: Fan, Xin, et al.
Publicado: (2022)

The Integrated Stress Response Is Tumorigenic and Constitutes a Therapeutic Liability in Somatotroph Adenomas
por: Li, Zhenye, et al.
Publicado: (2022)

Integrated multi-omics characterization of KRAS mutant colorectal cancer
por: Chong, Wei, et al.
Publicado: (2022)

Multi-platform-based characterization of ferroptosis in human colorectal cancer
por: Zhong, Yafang, et al.
Publicado: (2022)

Multi-omics analysis of Siglec family genes in cutaneous melanoma
por: Li, Kezhu, et al.
Publicado: (2023)

Multi-omic Characterization of COVID Hepatitis
por: Bhat, Mamatha
Publicado: (2022)

Proteogenomic characterization of ferroptosis regulators reveals therapeutic potential in glioblastoma
por: Wang, Xinzhuang, et al.
Publicado: (2023)

Nuclear liability
por: Weinstein, Jerry L
Publicado: (1962)

Liability of Hospitals
Publicado: (1909)

The Employer's Liability
Publicado: (1921)

Liability of Dentists
Publicado: (1883)

Liabilities of Patients
Publicado: (1890)

Liability of Physicians
Publicado: (1887)

Inhibiting SCD expression by IGF1R during lorlatinib therapy sensitizes melanoma to ferroptosis
por: Zeng, Furong, et al.
Publicado: (2023)

Computational identification of multi-omic correlates of anticancer therapeutic response
por: Stetson, Lindsay C, et al.
Publicado: (2014)

Molecular mechanisms of ferroptosis and the potential therapeutic targets of ferroptosis signaling pathways for glioblastoma
por: Zhang, Meng, et al.
Publicado: (2022)

Multi-modality data-driven analysis of diagnosis and treatment of psoriatic arthritis
por: Xu, Jing, et al.
Publicado: (2023)

The roles of ferroptosis regulatory gene SLC7A11 in renal cell carcinoma: A multi‐omics study
por: Xu, Fangshi, et al.
Publicado: (2021)

Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response
por: Valenti, Fabio, et al.
Publicado: (2021)

Systematically Prioritizing Functional Differentially Methylated Regions (fDMRs) by Integrating Multi-omics Data in Colorectal Cancer
por: Fan, Huihui, et al.
Publicado: (2015)

Decoding tumor heterogeneity in uveal melanoma: basement membrane genes as novel biomarkers and therapeutic targets revealed by multi-omics approaches for cancer immunotherapy
por: Li, Yunyue, et al.
Publicado: (2023)

Analysis of Ferroptosis-Mediated Modification Patterns and Tumor Immune Microenvironment Characterization in Uveal Melanoma
por: Jin, Yi, et al.
Publicado: (2021)

Erratum: Computational identification of multi-omic correlates of anticancer therapeutic response
por: Stetson, Lindsay C, et al.
Publicado: (2015)

CLCLSA: Cross-omics Linked embedding with Contrastive Learning and Self Attention for multi-omics integration with incomplete multi-omics data
por: Zhao, Chen, et al.
Publicado: (2023)

CLCLSA: Cross-omics Linked embedding with Contrastive Learning and Self Attention for multi-omics integration with incomplete multi-omics data
por: Zhao, Chen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g187jkvhqn1gtal9vjo80g9uag